AAAAAA

   
Results: 1-21 |
Results: 21
BONE-MARROW-DERIVED DENDRITIC CELLS DIRECTLY ACTIVATE ANTIGEN-SPECIFIC T-LYMPHOCYTES IN-VIVO
Authors: SCHNEEBERGER A KOSZIK F KOLESARIC A ELBEBURGER A STINGL G
Citation: A. Schneeberger et al., BONE-MARROW-DERIVED DENDRITIC CELLS DIRECTLY ACTIVATE ANTIGEN-SPECIFIC T-LYMPHOCYTES IN-VIVO, Journal of leukocyte biology, 1998, pp. 21-21
MURINE LANGERHANS CELLS CULTURED UNDER SERUM-FREE CONDITIONS MATURE INTO PATENT STIMULATORS OF PRIMARY IMMUNE-RESPONSES IN-VITRO AND IN-VIVO
Authors: KOCIKOVA A KOLESARIC A KOSZIK F STINGL G ELBEBURGER A
Citation: A. Kocikova et al., MURINE LANGERHANS CELLS CULTURED UNDER SERUM-FREE CONDITIONS MATURE INTO PATENT STIMULATORS OF PRIMARY IMMUNE-RESPONSES IN-VITRO AND IN-VIVO, The Journal of immunology (1950), 161(8), 1998, pp. 4033-4041
WHY IS CHRONIC LYME BORRELIOSIS CHRONIC
Authors: ABERER E KOSZIK F SILBERER M
Citation: E. Aberer et al., WHY IS CHRONIC LYME BORRELIOSIS CHRONIC, Clinical infectious diseases, 25, 1997, pp. 64-70
BONE-MARROW-DERIVED DENDRITIC CELLS DIRECTLY ACTIVATE ANTIGEN-SPECIFIC T-CELLS IN-VIVO
Authors: SCHNEEBERGER A KOSZIK F KOLESARIC A ELBEBURGER A STINGL G
Citation: A. Schneeberger et al., BONE-MARROW-DERIVED DENDRITIC CELLS DIRECTLY ACTIVATE ANTIGEN-SPECIFIC T-CELLS IN-VIVO, Journal of investigative dermatology, 109(2), 1997, pp. 65-65
MURINE LANGERHANS CELLS GENERATED UNDER SERUM-FREE CONDITIONS - IMMUNOPHENOTYPE AND STIMULATORY CAPACITIES
Authors: KOCIKOVA A OLT S KOSZIK F SCHNEEBERGER A STINGL G ELBEBURGER A
Citation: A. Kocikova et al., MURINE LANGERHANS CELLS GENERATED UNDER SERUM-FREE CONDITIONS - IMMUNOPHENOTYPE AND STIMULATORY CAPACITIES, Journal of investigative dermatology, 108(4), 1997, pp. 435-435
THE RELATIVE CONTRIBUTION OF DIRECT VERSUS INDIRECT PRESENTATION IN PRIMING FOR CONTACT HYPERSENSITIVITY BY MHC CLASS-I-II- APC IN-VIVO( CLASS)
Authors: KOLESARIC A KOSZIK F STINGL G ELBE A
Citation: A. Kolesaric et al., THE RELATIVE CONTRIBUTION OF DIRECT VERSUS INDIRECT PRESENTATION IN PRIMING FOR CONTACT HYPERSENSITIVITY BY MHC CLASS-I-II- APC IN-VIVO( CLASS), The FASEB journal, 10(6), 1996, pp. 2638-2638
LOSS OF TUMORIGENICITY OF INTERLEUKIN-2 PRODUCING M-3 MELANOMA-CELLS IS DUE TO INFILTRATING LEUKOCYTES - NK-CELLS PLAY A MAJOR ROLE
Authors: KOSZIK F SCHNEEBERGER A SCHMIDT W STROMMER S KUTIL R STINGL G
Citation: F. Koszik et al., LOSS OF TUMORIGENICITY OF INTERLEUKIN-2 PRODUCING M-3 MELANOMA-CELLS IS DUE TO INFILTRATING LEUKOCYTES - NK-CELLS PLAY A MAJOR ROLE, Journal of investigative dermatology, 107(3), 1996, pp. 6-6
IL-4 ENHANCES THE YIELD AND THE IMMUNOSTIMULATORY POTENCY OF MURINE BONE-MARROW-DERIVED DENDRITIC CELLS
Authors: SCHNEEBERGER A KOSZIK F LENZ P KOLESARIC A SCHEINECKER C STRUNK D GRAUER O KAMPGEN E ELBE A STINGL G
Citation: A. Schneeberger et al., IL-4 ENHANCES THE YIELD AND THE IMMUNOSTIMULATORY POTENCY OF MURINE BONE-MARROW-DERIVED DENDRITIC CELLS, Journal of investigative dermatology, 107(3), 1996, pp. 232-232
THE RELATIVE CONTRIBUTION OF DIRECT VERSUS INDIRECT PRESENTATION IN PRIMING FOR CONTACT HYPERSENSITIVITY BY MHC CLASS-I-II- DENDRITIC CELLS( CLASS)
Authors: KOLESARIC A KOSZIK F SCHNEEBERGER A STINGL G ELBE A
Citation: A. Kolesaric et al., THE RELATIVE CONTRIBUTION OF DIRECT VERSUS INDIRECT PRESENTATION IN PRIMING FOR CONTACT HYPERSENSITIVITY BY MHC CLASS-I-II- DENDRITIC CELLS( CLASS), Journal of investigative dermatology, 107(3), 1996, pp. 234-234
TUMOR CELL-BEARING SKIN TRANSPLANTS AS POTENT IMMUNOGENS FOR PROTECTIVE IMMUNITY AGAINST CANCER
Authors: SCHNEEBERGER A KUTIL R KOSZIK F LENZ P STINGL G
Citation: A. Schneeberger et al., TUMOR CELL-BEARING SKIN TRANSPLANTS AS POTENT IMMUNOGENS FOR PROTECTIVE IMMUNITY AGAINST CANCER, Journal of investigative dermatology, 106(4), 1996, pp. 701-701
LOSS OF TUMORIGENICITY OF IL-2-PRODUCING MURINE MELANOMA-CELLS IS DEPENDENT ON THE HOSTS IMMUNE-SYSTEM AND THE AMOUNT OF IL-2 PRODUCED
Authors: KOSZIK F SCHNEEBERGER A SCHMIDT W STROMMER S KUTIL R STINGL G
Citation: F. Koszik et al., LOSS OF TUMORIGENICITY OF IL-2-PRODUCING MURINE MELANOMA-CELLS IS DEPENDENT ON THE HOSTS IMMUNE-SYSTEM AND THE AMOUNT OF IL-2 PRODUCED, Journal of investigative dermatology, 106(4), 1996, pp. 757-757
PRIMING OF TUMOR-SPECIFIC T-CELLS IN THE DRAINING LYMPH-NODES AFTER IMMUNIZATION WITH INTERLEUKIN 2-SECRETING TUMOR-CELLS - 3 CONSECUTIVE STAGES MAY BE REQUIRED FOR SUCCESSFUL TUMOR VACCINATION
Authors: MAASS G SCHMIDT W BERGER M SCHILCHER F KOSZIK F SCHNEEBERGER A STINGL G BIRNSTIEL ML SCHWEIGHOFFER T
Citation: G. Maass et al., PRIMING OF TUMOR-SPECIFIC T-CELLS IN THE DRAINING LYMPH-NODES AFTER IMMUNIZATION WITH INTERLEUKIN 2-SECRETING TUMOR-CELLS - 3 CONSECUTIVE STAGES MAY BE REQUIRED FOR SUCCESSFUL TUMOR VACCINATION, Proceedings of the National Academy of Sciences of the United Statesof America, 92(12), 1995, pp. 5540-5544
DOWN-REGULATION OF MHC CLASS-II MOLECULES ON LANGERHANS CELLS IN ACRODERMATITIS CHRONICA ATROPHICANS
Authors: SILBERER M KOSZIK F STINGL G ABERER E
Citation: M. Silberer et al., DOWN-REGULATION OF MHC CLASS-II MOLECULES ON LANGERHANS CELLS IN ACRODERMATITIS CHRONICA ATROPHICANS, Journal of investigative dermatology, 105(3), 1995, pp. 473-473
IMMUNOLOGICAL HOST-DEFENSE IN MELANOMA - DELINEATION OF EFFECTOR MECHANISMS INVOLVED AND OF STRATEGIES FOR THE AUGMENTATION OF THEIR EFFICACY
Authors: SCHNEEBERGER A KOSZIK F STINGL G
Citation: A. Schneeberger et al., IMMUNOLOGICAL HOST-DEFENSE IN MELANOMA - DELINEATION OF EFFECTOR MECHANISMS INVOLVED AND OF STRATEGIES FOR THE AUGMENTATION OF THEIR EFFICACY, Journal of investigative dermatology, 105(1), 1995, pp. 110-116
IMMUNIZATION WITH IL-2-TRANSFECTED M-3 MELANOMA-CELLS OVERCOMES TUMOR-INDUCED IMMUNOSUPPRESSION
Authors: SCHNEEBERGER A KUTIL R KOSZIK F LAUB R BUSCHLE M WAGNER E BIRNSTIEL M STINGL G
Citation: A. Schneeberger et al., IMMUNIZATION WITH IL-2-TRANSFECTED M-3 MELANOMA-CELLS OVERCOMES TUMOR-INDUCED IMMUNOSUPPRESSION, Journal of investigative dermatology, 104(4), 1995, pp. 681-681
ELICITATION OF A SYSTEMIC AND PROTECTIVE ANTIMELANOMA IMMUNE-RESPONSEBY AN IL-2-BASED VACCINE - ASSESSMENT OF CRITICAL CELLULAR AND MOLECULAR-PARAMETERS
Authors: ZATLOUKAL K SCHNEEBERGER A BERGER M SCHMIDT W KOSZIK F KUTIL R COTTEN M WAGNER E BUSCHLE M MAASS G PAYER E STINGL G BIRNSTIEL ML
Citation: K. Zatloukal et al., ELICITATION OF A SYSTEMIC AND PROTECTIVE ANTIMELANOMA IMMUNE-RESPONSEBY AN IL-2-BASED VACCINE - ASSESSMENT OF CRITICAL CELLULAR AND MOLECULAR-PARAMETERS, The Journal of immunology, 154(7), 1995, pp. 3406-3419
ANTITUMOR EFFECTOR MECHANISMS GENERATED BY VACCINATION WITH INTERLEUKIN-2 TRANSFECTED MURINE MELANOMA-CELLS
Authors: SCHNEEBERGER A KOSZIK F ZATLOUKAL K KUTIL R ELBE A WAGNER E BIRNSTIEL ML STINGL G
Citation: A. Schneeberger et al., ANTITUMOR EFFECTOR MECHANISMS GENERATED BY VACCINATION WITH INTERLEUKIN-2 TRANSFECTED MURINE MELANOMA-CELLS, Journal of investigative dermatology, 103(3), 1994, pp. 408-408
EXPRESSION OF MONOCLONAL-ANTIBODY HECA-452-DEFINED E-SELECTIN LIGANDSON LANGERHANS CELLS IN NORMAL AND DISEASED SKIN
Authors: KOSZIK F STRUNK D SIMONITSCH I PICKER LJ STINGL G PAYER E
Citation: F. Koszik et al., EXPRESSION OF MONOCLONAL-ANTIBODY HECA-452-DEFINED E-SELECTIN LIGANDSON LANGERHANS CELLS IN NORMAL AND DISEASED SKIN, Journal of investigative dermatology, 102(5), 1994, pp. 773-780
IMMUNIZATION WITH IL-2-TRANSFECTED M-3 MELANOMA-CELLS PROTECTS MICE AGAINST SUBSEQUENT CHALLENGE WITH WILD-TYPE M-3 CELLS - CHARACTERIZATION OF THE EFFECTOR POPULATIONS
Authors: KOSZIK F SCHNEEBERGER A ZATLOUKAL K PAYER E ELBE A WAGNER E BIRNSTIEL ML STINGL G
Citation: F. Koszik et al., IMMUNIZATION WITH IL-2-TRANSFECTED M-3 MELANOMA-CELLS PROTECTS MICE AGAINST SUBSEQUENT CHALLENGE WITH WILD-TYPE M-3 CELLS - CHARACTERIZATION OF THE EFFECTOR POPULATIONS, Journal of investigative dermatology, 102(4), 1994, pp. 583-583
MECHANISMS LEADING TO INTERLEUKIN-2 MEDIATED IMMUNITY AGAINST M3 MURINE MELANOMA
Authors: SCHNEEBERGER A ZATLOUKAL K KOSZIK F PAYER E ELBE A WAGNER E BIRNSTIEL ML STINGL G
Citation: A. Schneeberger et al., MECHANISMS LEADING TO INTERLEUKIN-2 MEDIATED IMMUNITY AGAINST M3 MURINE MELANOMA, Journal of investigative dermatology, 102(4), 1994, pp. 583-583
IMMUNOMORPHOLOGICAL CHARACTERIZATION OF FC-EPSILON-RI-BEARING CELLS WITHIN THE HUMAN DERMIS
Authors: OSTERHOFF B RAPPERSBERGER K WANG BH KOSZIK F OCHIAI K KINET JP STINGL G
Citation: B. Osterhoff et al., IMMUNOMORPHOLOGICAL CHARACTERIZATION OF FC-EPSILON-RI-BEARING CELLS WITHIN THE HUMAN DERMIS, Journal of investigative dermatology, 102(3), 1994, pp. 315-320
Risultati: 1-21 |